1. Home
  2. DLTH vs RCEL Comparison

DLTH vs RCEL Comparison

Compare DLTH & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Duluth Holdings Inc. Class B

DLTH

Duluth Holdings Inc. Class B

HOLD

Current Price

$2.35

Market Cap

121.1M

ML Signal

HOLD

Logo Avita Medical Inc.

RCEL

Avita Medical Inc.

HOLD

Current Price

$3.28

Market Cap

102.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DLTH
RCEL
Founded
1989
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
121.1M
102.5M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
DLTH
RCEL
Price
$2.35
$3.28
Analyst Decision
Buy
Buy
Analyst Count
1
4
Target Price
$7.00
$8.67
AVG Volume (30 Days)
209.0K
202.3K
Earning Date
12-16-2025
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$590,561,000.00
$72,401,000.00
Revenue This Year
N/A
$13.12
Revenue Next Year
N/A
$27.56
P/E Ratio
N/A
N/A
Revenue Growth
N/A
20.59
52 Week Low
$1.58
$3.22
52 Week High
$4.66
$14.16

Technical Indicators

Market Signals
Indicator
DLTH
RCEL
Relative Strength Index (RSI) 44.36 34.47
Support Level $2.02 $3.22
Resistance Level $2.15 $3.61
Average True Range (ATR) 0.11 0.18
MACD 0.03 0.01
Stochastic Oscillator 85.74 12.24

Price Performance

Historical Comparison
DLTH
RCEL

About DLTH Duluth Holdings Inc. Class B

Duluth Holdings Inc is an apparel brand in the United States. The company offers shirts, pants, and casual wear for men and women under brands like Alaskan Hardgear, Armachillo, Ballroom, Cab Commander, Crouch Gusset, Dry on the Fly, Duluth Trading Co, Duluthflex, Fire Hose, Longtail T, No Polo Shirt, No Yank, Wild Boar, and others. The Company's revenue consists of the sale of apparel, footwear, and hard goods. The company operates in a single operating segment.

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: